[Glycemic control in type 2 diabetic patients in public and private healthcare service].

OBJECTIVE To compare the treatment of type 2 diabetic patients from a private clinic with those of a public health service. METHODS It was designed a retrospective cohort study, including 80 patients attended at the Central Clinic of Universidade de Caxias do Sul (AMCE), which is related to the Single Health System, and 277 patients attended at a private clinic, whom consult between May 2001 and October 2007. RESULTS Patients attended at AMCE showed a worse metabolic control, although only the values of A1c and total cholesterol have reached statistical significance. Both groups had an improvement in almost all the metabolic parameters. The use of insulin at the end of follow-up (B = 4,66; CI95% = 2,18 - 9,89; p < 0,001) and initial A1c (B = 1,42; CI95% = 1,16 - 1,74; p = 0,001) were determinant of a worse glycemic control. The frequency of visits was determinant of a better control (B = 0,72; CI 95% = 0,55 - 0,93; p = 0,01). CONCLUSIONS The variables such as the initial A1c and the frequency of visits, which may be considered as indicators of patients' access to the heath system, have greater impact on the control of diabetes than the place where the patients are treated.

[1]  H. von Gizycki,et al.  Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. , 2002, Diabetes care.

[2]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[3]  H. Rodbard,et al.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[4]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[5]  Peter Lindgren,et al.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary , 2007 .

[6]  L. Franco,et al.  Multicenter Study of the Prevalence of Diabetes Mellitus and Impaired Glucose Tolerance in the Urban Brazilian Population Aged 30–69 yr , 1992, Diabetes Care.

[7]  K. Narayan,et al.  The Global Burden of Diabetes , 2010 .

[8]  M. Shichiri,et al.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. , 2000, Diabetes care.

[9]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[10]  入江 潤一郎,et al.  Glucose control and vascular complications in veterans with type 2 diabetes , 2009 .

[11]  B. Zinman,et al.  Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy , 2009, Diabetes Care.

[12]  J. Rosas Guzmán,et al.  Control of type 2 diabetes mellitus among general practitioners in private practice in nine countries of Latin America. , 2007, Revista panamericana de salud publica = Pan American journal of public health.

[13]  Daniel Panarotto,et al.  Levantamento dos métodos de análise de hemoglobina glicada utilizados em laboratórios da Serra Gaúcha , 2005 .

[14]  O. Pedersen,et al.  MULTIFACTORIAL INTERVENTION AND CARDIOVASCULAR DISEASE IN PATIENTS WITH TYPE 2 DIABETES , 2003 .

[15]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[16]  Michael E. Miller,et al.  Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.

[17]  S. Schinner,et al.  Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .

[18]  S. Feld,et al.  The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: The AACE System of Intensive Diabetes Self-Management - 2002 Update , 2002 .

[19]  O. Tanner Intensive versus Conventional Glucose Control in Critically Ill Patients , 2009 .

[20]  M. Fowler,et al.  Clinical Practice Recommendations , 2009, Clinical Diabetes.

[21]  K. Secnik,et al.  Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study. , 2007, Clinical therapeutics.

[22]  Idf Clinical Guidelines Task Force Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[23]  V. Basevi Standards of medical care in diabetes--2007. , 2009, Diabetes care.

[24]  O. Pedersen,et al.  Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.

[25]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes , 2004 .

[26]  H. King,et al.  Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.

[27]  B. Zinman,et al.  Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy , 2008, Diabetes Care.

[28]  J. Klotsche,et al.  Diabetes Mellitus in German Primary Care: quality of glycaemic control and subpopulations not well controlled - results of the DETECT study. , 2008, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[29]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[30]  B. Jönsson,et al.  Revealing the cost of Type II diabetes in Europe , 2002, Diabetologia.